Number of the records: 1
skúšanie klinické, fáza IV, ako téma
SYS d017327 LBL 00000cz--a2200000n--4500 005 20250606212925.9 008 920513|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a E05.318.372.250.250.230 065 $a E05.337.800.200 065 $a N05.715.360.330.250.250.230 065 $a N06.850.520.450.250.250.230 066 $a 01 $c 03 089 $a 615.036 150 $a skúšanie klinické, fáza IV, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $2 slo 450 $w v $a pokusy klinické, štvrtá fáza, ako téma $2 slo 450 $w v $a testy klinické, štvrtá fáza, ako téma $2 slo 450 $w v $a štúdie klinické, fáza IV, ako téma $2 slo 550 $7 sllk_us_auth*d015337 $Y Multicenter Studies as Topic $w b $a štúdie multicentrické ako téma 550 $7 sllk_us_auth*d064420 $Y Drug-Related Side Effects and Adverse Reactions $w p $a účinky liekov vedľajšie a nežiaduce reakcie liekov 550 $7 sllk_us_auth*d064420 $Y Drug-Related Side Effects and Adverse Reactions $w b $a účinky liekov vedľajšie a nežiaduce reakcie liekov 665 $a 2008(1993) $2 eng 665 $a Clinical Trials (1980-1992) $2 eng 680 9-
$i Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries. $2 eng 680 $a for general design, methodology, economics, etc. of phase IV clinical trials; a different heading CLINICAL TRIAL, PHASE IV is used for reports of a specific phase IV clinical trial $2 eng 750 -2
$a Clinical Trials, Phase IV as Topic $2 eng 980 $x M
Number of the records: 1